BRUKER CORPORATION Research and Development Expense
BRUKER CORPORATION (BRKR) reported Research and Development Expense of $94.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- BRUKER CORPORATION research and development expense for the quarter ending 2026-06-30 was $94.30M, a 5.89% decline year-over-year.
- BRUKER CORPORATION research and development expense for the quarter ending 2026-03-31 was $101.30M, a 4.33% increase year-over-year.
- BRUKER CORPORATION research and development expense for the quarter ending 2025-12-31 was $99.60M, a 4.60% decline year-over-year.
- BRUKER CORPORATION research and development expense for the quarter ending 2025-09-30 was $98.30M, a 0.20% increase year-over-year.
- BRUKER CORPORATION research and development expense for fiscal 2025 was $395.20M, a 4.97% increase from fiscal 2024.
- BRUKER CORPORATION research and development expense for fiscal 2024 was $376.50M, a 27.71% increase from fiscal 2023.
- BRUKER CORPORATION research and development expense for fiscal 2023 was $294.80M, a 24.97% increase from fiscal 2022.
- BRUKER CORPORATION research and development expense for fiscal 2022 was $235.90M, a 6.84% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $94.30M 10-Q · filed 2026-08-05 | $195.60M 10-Q · filed 2026-08-05 | $295.20M derived: sum of 3 quarters · filed 2026-08-05 | $393.50M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $101.30M 10-Q · filed 2026-05-07 | $200.90M derived: sum of 2 quarters · filed 2026-05-07 | $299.20M derived: sum of 3 quarters · filed 2026-05-07 | $399.40M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $99.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $197.90M derived: sum of 2 quarters · filed 2026-02-27 | $298.10M derived: sum of 3 quarters · filed 2026-08-05 | $395.20M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $98.30M 10-Q · filed 2025-11-05 | $198.50M derived: sum of 2 quarters · filed 2026-08-05 | $295.60M 10-Q · filed 2025-11-05 | $400.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $100.20M 10-Q · filed 2026-08-05 | $197.30M 10-Q · filed 2026-08-05 | $301.70M derived: sum of 3 quarters · filed 2026-08-05 | $399.80M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $97.10M 10-Q · filed 2026-05-07 | $201.50M derived: sum of 2 quarters · filed 2026-05-07 | $299.60M derived: sum of 3 quarters · filed 2026-05-07 | $391.80M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $104.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $202.50M derived: sum of 2 quarters · filed 2026-02-27 | $294.70M derived: sum of 3 quarters · filed 2026-02-27 | $376.50M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $98.10M 10-Q · filed 2025-11-05 | $190.30M derived: sum of 2 quarters · filed 2025-11-05 | $272.10M 10-Q · filed 2025-11-05 | $355.60M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $92.20M 10-Q · filed 2025-08-06 | $174.00M 10-Q · filed 2025-08-06 | $257.50M derived: sum of 3 quarters · filed 2026-02-27 | $328.80M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $81.80M 10-Q · filed 2025-05-07 | $165.30M derived: sum of 2 quarters · filed 2026-02-27 | $236.60M derived: sum of 3 quarters · filed 2026-02-27 | $307.60M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $83.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $154.80M derived: sum of 2 quarters · filed 2026-02-27 | $225.80M derived: sum of 3 quarters · filed 2026-02-27 | $294.80M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $71.30M 10-Q · filed 2024-11-07 | $142.30M derived: sum of 2 quarters · filed 2024-11-07 | $211.30M 10-Q · filed 2024-11-07 | $274.80M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $71.00M 10-Q · filed 2024-08-09 | $140.00M 10-Q · filed 2024-08-09 | $203.50M derived: sum of 3 quarters · filed 2025-03-03 | $259.70M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $69.00M 10-Q · filed 2024-05-10 | $132.50M derived: sum of 2 quarters · filed 2025-03-03 | $188.70M derived: sum of 3 quarters · filed 2025-03-03 | $248.30M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $63.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $119.70M derived: sum of 2 quarters · filed 2025-03-03 | $179.30M derived: sum of 3 quarters · filed 2025-03-03 | $235.90M 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $56.20M 10-Q · filed 2023-11-09 | $115.80M derived: sum of 2 quarters · filed 2023-11-09 | $172.40M 10-Q · filed 2023-11-09 | $230.50M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $59.60M 10-Q · filed 2023-08-09 | $116.20M 10-Q · filed 2023-08-09 | $174.30M derived: sum of 3 quarters · filed 2024-02-29 | $226.40M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $56.60M 10-Q · filed 2023-05-10 | $114.70M derived: sum of 2 quarters · filed 2024-02-29 | $166.80M derived: sum of 3 quarters · filed 2024-02-29 | $222.60M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $58.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $110.20M derived: sum of 2 quarters · filed 2024-02-29 | $166.00M derived: sum of 3 quarters · filed 2024-02-29 | $220.80M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $52.10M 10-Q · filed 2022-11-04 | $107.90M derived: sum of 2 quarters · filed 2022-11-04 | $162.70M 10-Q · filed 2022-11-04 | $219.80M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $55.80M 10-Q · filed 2022-08-05 | $110.60M 10-Q · filed 2022-08-05 | $167.70M derived: sum of 3 quarters · filed 2023-03-01 | $216.00M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $54.80M 10-Q · filed 2022-05-06 | $111.90M derived: sum of 2 quarters · filed 2023-03-01 | $160.20M derived: sum of 3 quarters · filed 2023-03-01 | $204.30M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $57.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $105.40M derived: sum of 2 quarters · filed 2023-03-01 | $149.50M derived: sum of 3 quarters · filed 2023-03-01 | $198.00M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $48.30M 10-Q · filed 2021-11-05 | $92.40M derived: sum of 2 quarters · filed 2021-11-05 | $140.90M 10-Q · filed 2021-11-05 | $187.60M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $44.10M 10-Q · filed 2021-08-05 | $92.60M 10-Q · filed 2021-08-05 | $139.30M derived: sum of 3 quarters · filed 2022-02-28 | $185.40M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $48.50M 10-Q · filed 2021-05-10 | $95.20M derived: sum of 2 quarters · filed 2022-02-28 | $141.30M derived: sum of 3 quarters · filed 2022-02-28 | $189.80M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $46.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $92.80M derived: sum of 2 quarters · filed 2022-02-28 | $141.30M derived: sum of 3 quarters · filed 2022-02-28 | $187.70M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $46.10M 10-Q · filed 2020-11-06 | $94.60M derived: sum of 2 quarters · filed 2020-11-06 | $141.00M 10-Q · filed 2020-11-06 | $185.80M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $48.50M 10-Q · filed 2020-08-07 | $94.90M 10-Q · filed 2020-08-07 | $139.70M derived: sum of 3 quarters · filed 2021-03-01 | $181.50M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $46.40M 10-Q · filed 2020-05-11 | $91.20M derived: sum of 2 quarters · filed 2021-03-01 | $133.00M derived: sum of 3 quarters · filed 2021-03-01 | $176.60M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $44.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $86.60M derived: sum of 2 quarters · filed 2021-03-01 | $130.20M derived: sum of 3 quarters · filed 2021-03-01 | $173.40M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $41.80M 10-Q · filed 2019-11-04 | $85.40M derived: sum of 2 quarters · filed 2019-11-04 | $128.60M 10-Q · filed 2019-11-04 | $171.70M derived: sum of 4 quarters · filed 2020-03-27 | ||||
| 2018-06-30 | $43.60M 10-Q · filed 2019-08-09 | $86.80M 10-Q · filed 2019-08-09 | $129.90M derived: sum of 3 quarters · filed 2020-03-27 | $170.50M derived: sum of 4 quarters · filed 2020-03-27 | ||||
| 2018-03-31 | $43.20M 10-Q · filed 2019-05-08 | $86.30M derived: sum of 2 quarters · filed 2020-03-27 | $126.90M derived: sum of 3 quarters · filed 2020-03-27 | $167.20M derived: sum of 4 quarters · filed 2020-03-27 | ||||
| 2017-12-31 | $43.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $83.70M derived: sum of 2 quarters · filed 2020-03-27 | $124.00M derived: sum of 3 quarters · filed 2020-03-27 | $161.60M 10-K · filed 2020-03-27 | $162.70M 10-K · filed 2018-03-16 | |||
| 2017-09-30 | $40.60M 10-Q · filed 2018-11-09 | $40.90M 10-Q · filed 2017-11-09 | $80.90M derived: sum of 2 quarters · filed 2018-11-09 | $118.50M 10-Q · filed 2018-11-09 | $119.20M 10-Q · filed 2017-11-09 | $155.60M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $40.30M 10-Q · filed 2018-08-09 | $40.70M 10-Q · filed 2017-08-09 | $77.90M 10-Q · filed 2018-08-09 | $78.30M 10-Q · filed 2017-08-09 | $115.00M derived: sum of 3 quarters · filed 2019-03-01 | $152.90M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $37.60M 10-Q · filed 2018-05-10 | $74.70M derived: sum of 2 quarters · filed 2019-03-01 | $112.60M derived: sum of 3 quarters · filed 2019-03-01 | $149.40M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $37.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $75.00M derived: sum of 2 quarters · filed 2019-03-01 | $111.80M derived: sum of 3 quarters · filed 2019-03-01 | $147.90M 10-K · filed 2019-03-01 | $149.00M 10-K · filed 2017-03-01 | |||
| 2016-09-30 | $37.90M 10-Q · filed 2017-11-09 | $74.70M derived: sum of 2 quarters · filed 2017-11-09 | $110.80M 10-Q · filed 2017-11-09 | $147.50M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $36.80M 10-Q · filed 2017-08-09 | $72.90M 10-Q · filed 2017-08-09 | $109.60M derived: sum of 3 quarters · filed 2018-03-16 | $143.90M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $36.10M 10-Q · filed 2017-05-10 | $72.80M derived: sum of 2 quarters · filed 2018-03-16 | $107.10M derived: sum of 3 quarters · filed 2018-03-16 | $144.60M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $36.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $71.00M derived: sum of 2 quarters · filed 2018-03-16 | $108.50M derived: sum of 3 quarters · filed 2018-03-16 | $145.70M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $34.30M 10-Q · filed 2016-11-09 | $71.80M derived: sum of 2 quarters · filed 2016-11-09 | $109.00M 10-Q · filed 2016-11-09 | $150.60M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $37.50M 10-Q · filed 2016-08-05 | $74.70M 10-Q · filed 2016-08-05 | $116.30M derived: sum of 3 quarters · filed 2017-03-01 | $158.40M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $37.20M 10-Q · filed 2016-05-06 | $78.80M derived: sum of 2 quarters · filed 2017-03-01 | $120.90M derived: sum of 3 quarters · filed 2017-03-01 | $165.40M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $41.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $83.70M derived: sum of 2 quarters · filed 2017-03-01 | $128.20M derived: sum of 3 quarters · filed 2017-03-01 | $174.20M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $42.10M 10-Q · filed 2015-11-06 | $86.60M derived: sum of 2 quarters · filed 2015-11-06 | $132.60M 10-Q · filed 2015-11-06 | $181.70M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $44.50M 10-Q · filed 2015-08-07 | $90.50M 10-Q · filed 2015-08-07 | $139.60M derived: sum of 3 quarters · filed 2016-02-29 | $185.10M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $46.00M 10-Q · filed 2015-05-08 | $95.10M derived: sum of 2 quarters · filed 2016-02-29 | $140.60M derived: sum of 3 quarters · filed 2016-02-29 | $187.10M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $49.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $94.60M derived: sum of 2 quarters · filed 2016-02-29 | $141.10M derived: sum of 3 quarters · filed 2016-02-29 | $190.50M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $45.50M 10-Q · filed 2014-11-07 | $92.00M derived: sum of 2 quarters · filed 2014-11-07 | $141.40M 10-Q · filed 2014-11-07 | $191.70M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $46.50M 10-Q · filed 2014-08-08 | $95.90M 10-Q · filed 2014-08-08 | $146.20M derived: sum of 3 quarters · filed 2015-02-27 | $191.10M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $49.40M 10-Q · filed 2014-05-09 | $99.70M derived: sum of 2 quarters · filed 2015-02-27 | $144.60M derived: sum of 3 quarters · filed 2015-02-27 | $196.50M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $50.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $95.20M derived: sum of 2 quarters · filed 2015-02-27 | $147.10M derived: sum of 3 quarters · filed 2015-02-27 | $195.30M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $44.90M 10-Q · filed 2013-11-08 | $96.80M derived: sum of 2 quarters · filed 2013-11-08 | $145.00M 10-Q · filed 2013-11-08 | $189.70M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $51.90M 10-Q · filed 2013-08-08 | $100.10M 10-Q · filed 2013-08-08 | $144.80M derived: sum of 3 quarters · filed 2014-02-27 | $188.30M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $48.20M 10-Q · filed 2013-05-09 | $92.90M derived: sum of 2 quarters · filed 2014-02-27 | $136.40M derived: sum of 3 quarters · filed 2014-02-27 | $180.70M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $44.70M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $88.20M derived: sum of 2 quarters · filed 2014-02-27 | $132.50M derived: sum of 3 quarters · filed 2014-02-27 | $177.20M 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $43.50M 10-Q · filed 2012-11-08 | $87.80M derived: sum of 2 quarters · filed 2012-11-08 | $132.50M 10-Q · filed 2012-11-08 | $177.40M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $44.30M 10-Q · filed 2012-08-09 | $89.00M 10-Q · filed 2012-08-09 | $133.90M derived: sum of 3 quarters · filed 2013-02-28 | $166.40M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $44.70M 10-Q · filed 2012-05-09 | $89.60M derived: sum of 2 quarters · filed 2013-02-28 | $122.10M derived: sum of 3 quarters · filed 2013-02-28 | $153.30M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $44.90M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $77.40M derived: sum of 2 quarters · filed 2013-02-28 | $108.60M derived: sum of 3 quarters · filed 2013-02-28 | $141.40M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $32.50M 10-Q · filed 2011-11-09 | $63.70M derived: sum of 2 quarters · filed 2011-11-09 | $96.50M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $31.20M 10-Q · filed 2011-08-09 | $64.00M 10-Q · filed 2011-08-09 | ||||||
| 2010-03-31 | $32.80M 10-Q · filed 2011-05-09 | |||||||
| 2009-12-31 | $126.40M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |